Education
School ¡X Major ¡X Degree | Duration |
---|---|
°ê¥ß»OÆW¤j¾Ç ¡X ÃIJz¾Ç¬ã¨s©Ò(²¦) ¡X ³Õ¤h Doctorate, Pharmacology, National Taiwan University |
2002/09 ¡X 2008/06 |
°ê¥ß»OÆW¤j¾Ç ¡X ÃIJz¾Ç¬ã¨s©Ò(²¦) ¡X ºÓ¤h Master, Pharmacology, National Taiwan University |
2000/09 ¡X 2002/07 |
°ª¶¯Âå¾Ç¤j¾Ç ¡X ÃľǨt(²¦) ¡X ¾Ç¤h Bachelor, Pharmacy, Kaohsiung Medical University |
1996/09 ¡X 2000/06 |
Intramural Experience
Office/Department/Institute | Position | Duration |
---|---|---|
¾Ç¤h«áÂå¾Ç¨t School of Post-Baccalaureate Medicine | Professor | 2023/08/01 ¡X |
¾Ç¤h«áÂå¾Ç¨t School of Post-Baccalaureate Medicine | Assistant Professor | 2020/08/01 ¡X 2020/01/31 |
¾Ç¤h«áÂå¾Ç¨t School of Post-Baccalaureate Medicine | Associate Professor | 2020/02/01 ¡X 2023/07/31 |
ÃIJz¾Ç¬ì Department of Pharmacology | Assistant Professor | 2017/02/01 ¡X 2020/07/31 |
Extramural Experience
DEPNO | Position- Office/Department/Institute | Duration |
---|---|---|
±Ó´fÂåÅ@ºÞ²z±M¬ì¾Ç®Õ | §U²z±Ð±Â | 1010909 ¡X 1060131 |
Discipline
Research & Technology Platform Open to the Outside
Interested Area(s)for Interdisciplinary Research
¾¯«¬§ïÅÜ¡Gµ²ºcÅܤÆ
Area(s) of Expertise & Research
¬ì¾Ç¤¤ÃÄÃIJz±´°Q ¦ÑÃÄ·s¥Î §ÜÀùº[¯«¸gµoª¢ÃĪ«¶}µo §í¨î²O¤ÚºÞ·s¥ÍÃĪ«¶}µo
Pharmacological action of traditional Chinese medicine, drug repurposing, development of anti-cancer and anti-neuroinflammation drugs, development of drugs for inhibiting lymphangiogenesis
Publication
NO | Publication |
---|---|
1 | ªÚ¼Ì¾J¡A¤@ºØ´Óª«ªÚ»¤Æ¦Xª«¡A¦b©¬ª÷´Ë¤ó¯g¹êÅç¼Ò«¬¤¤¨ã«OÅ@¦h¤ÚÓi¯«¸g¤¸¤Î§ïµ½¹B°Ê¥\¯à©M°©Àf¦Ù±j«×ªº§@¥Î Linalool, a Fragrance Compound in Plants, Protects Dopaminergic Neurons and Improves Motor Function and Skeletal Muscle Strength in Experimental Models of Parkinson's Disease. |
2 | Hernandonine ¤¶¾Éªº¨x²ÓMÀù¦Û¾½²ÓM¦º¤`¡Gp53 ©M YAP °T¸¹¸ô®|ªº¬Û¤¬§@¥Î Hernandonine-mediated autophagic cell death in hepatocellular carcinoma: Interplay of p53 and YAP signaling pathways |
3 | Rhopaloic Acid A ³z¹L JNK/BNIP3/Nix ¤¶¾Éªº²É½uÅé¦Û¾½Ä²µo¤fµÄÀù¤¤½u²ÉÅé·l¶Ë»¤¾Éªº²ÓMä¤` Rhopaloic acid A triggers mitochondria damage-induced apoptosis in oral cancer by JNK/BNIP3/Nix-mediated mitophagy |
4 | §ÜµßÐ`肽Piscidin 4³z¹LERK/SIRT1/PGC-1£\°T¸¹¸ô®|»¤¾É»H¯ÖÀùä¤` The Antimicrobial Peptide Tilapia Piscidin 4 Induced the Apoptosis of Bladder Cancer Through ERK/SIRT1/PGC-1£\ Signaling Pathway |
5 | Nobiletin l¥Íª« 5-acetoxy-6,7,8,3',4'-pentamethoxyflavone ³z¹L§í¨î¤p½¦½è²ÓM¤¤ªº TLR4/MyD88/MAPK °T¸¹³q¸ô©M STAT3 ¨Ó§í¨î¯«¸gª¢¯g Nobiletin derivative, 5-acetoxy-6,7,8,3',4'-pentamethoxyflavone, inhibits neuroinflammation through the inhibition of TLR4/MyD88/MAPK signaling pathways and STAT3 in microglia |
6 | ¦ÑÃÄ·s¥Î§Üºë¯«¯fÃĪ«¤T¬t©Ô嗪³z¹L ROS/¦Û¾½³~®|»¤¾É SLC7A11/GPX4 ½Õ±±ªº¤fµÄÀùÅK¦º¤` Repurposing of the Antipsychotic Trifluoperazine Induces SLC7A11/GPX4- Mediated Ferroptosis of Oral Cancer via the ROS/Autophagy Pathway |
7 | ¥Õªá¤¦¯ÀÂÇ¥ÑROS½Õ±±ªº¤º½èºôÀ£¤O©M²É½uÅé¥\¯à»Ùê³y¦¨§ÜÃĩʤfµÄÀù细Mä¤` Plumbagin induces the apoptosis of drug-resistant oral cancer in vitro and in vivo through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction |
8 | £\7 µÒÆP«¬¤A酰ÁxÆP¨üÅé¦b¸£³¡¯e¯f¤¤ªº¥Í²z¥\¯à©MªvÀøÀ³¥Î Physiologic Functions and Therapeutic Applications of £\7 Nicotinic Acetylcholine Receptor in Brain Disorders |
9 | Eugenosedin-A §ïµ½ªÎD¬ÛÃö°ª¦å¿}¸g¥Ñ½Õ±± ATP ±Ó·P©Ê¹[³q¹D¤Î¯Ø®q¯À¤Àªc¦b¯ØŦ¤A«¬²ÓM Eugenosedin-A improves obesity-related hyperglycemia by regulating ATP-sensitive K channels and insulin secretion in pancreatic £] cells. |
10 | 6-¥Ò®ñ°ò¶Àଳq¹L§í¨î TLR4/MyD88/p38 MAPK/NF-£eB ¨Ì¿à©Ê³q¸ô©M¿E¬¡ HO-1/NQO-1 «H¸¹³q¸ô¨Ó§í¨î¯×¦hÁÞ¨ë¿Eªº¤p½¦½è²ÓM¤¤ªº¯«¸gª¢¯g 6-methoxyflavone suppresses neuroinflammation in lipopolysaccharide- stimulated microglia through the inhibition of TLR4/MyD88/p38 MAPK/NF-£eB dependent pathways and the activation of HO-1/NQO-1 signaling |
11 | ²§¥Ì¯ó¯À³q¹L¸²µå¿}½Õ¸`³J¥Õ 78 ¤U½Õ§í¨îGÀù·F²ÓM¡B½Õ¸`¸~½F·LÀô¹Ò©M§í¨î¸~½F¥Íªø Isoliquiritigenin Inhibits Gastric Cancer Stemness, Modulates Tumor Microenvironment, and Suppresses Tumor Growth through Glucose-Regulated Protein 78 Downregulation |
12 | ¤ìÅð³q¹L²ÓMä¤`»¤¾Éªº½u²ÉÅé¥\¯à»Ùê©M HDAC-2 ¤¶¾Éªº«H¸¹¶Ç¾É§í¨î¤fµÄÀùªº¥Íªø Trichodermin inhibits the growth of oral cancer through apoptosis-induced mitochondrial dysfunction and HDAC-2-mediated signaling |
13 | ´â¤þ嗪¬O¤@ºØ§Üºë¯«¯fÃÄ¡A¥i³q¹L½Õ¸`¤H¤fµÄÀù¤¤PI3K / AKT / mTOR¤¶¾Éªº¦Û¾½³~®|¨Ó»¤¾ÉG2 / M´Áªýº¢©M²ÓMä¤` Chlorpromazine, an antipsychotic agent, induces G2/M phase arrest and apoptosis via regulation of the PI3K/AKT/mTOR-mediated autophagy pathways in human oral cancer |
14 | »óµÄÄé¬~²G¥~ªcÅ餤Öß³J¥Õ 5AC ÅãµÛ¤W½Õ¡A¥i¯à«P¶i COX-2¡BVEGF ©M MMP-9 ªºªí¹F¡G¹ï»ó®§¦×µo¯f¾÷¨îªº¼vÅT Mucin 5AC is significantly upregulated in exosomes from the nasal lavage fluid and may promote the expression of COX-2, VEGF and MMP-9: an implication in nasal polyp pathogenesis |
15 | Rhopaloic acid A ³q¹L ROS ¤¶¾Éªº«H¸¹¶Ç¾É¦b»H¯ÖÀù¤¤»¤¾É²ÓMä¤`¡B¦Û¾½©M MAPK ¿E¬¡ Rhopaloic acid A induces apoptosis, autophagy and MAPK activation through ROS-mediated signaling in bladder cancer |
16 | Loganin ¹w¨¾ CXCL12/CXCR4 ½Õ±±¯«¸g©Ê¯kµh³z¹L NLRP3µoª¢Åé¦b¯«¸g·l¶Ëªº¤j¹« Loganin prevents CXCL12/CXCR4-regulated neuropathic pain via the NLRP3 inflammasome axis in nerve-injured rats. |
17 | Heteronemin ³q¹L ARF-1 ©M MMP-9/VE-Cadherin/Vimentin §í¨î²O¤ÚºÞ¥Í¦¨ Heteronemin Suppresses Lymphangiogenesis through ARF-1 and MMP-9/VE-Cadherin/Vimentin |
18 | ZnO¯Ç¦ÌÁû²É³q¹L½u²ÉÅé¥\¯à»Ùê©Mp70S6K«H¸¹³q¸ô»¤¾É¤úÅiÅ쪬²ÓMÀù¤¤caspase¨Ì¿à©Êä¤` ZnO Nanoparticles Induced Caspase-Dependent Apoptosis in Gingival Squamous Cell Carcinoma through Mitochondrial Dysfunction and p70S6K Signaling Pathway |
19 | Hispidulin§í¨î¯×¦hÁÞ¿E¬¡ªºBV2¤p½¦½è²ÓMªº¯«¸gª¢¯g¡A¨Ã´î®zAkt¡ANF-£eB©MSTAT3³~®|ªº¿E¬¡¡C Hispidulin Inhibits Neuroinflammation in Lipopolysaccharide-Activated BV2 Microglia and Attenuates the Activation of Akt, NF-£eB, and STAT3 Pathway |
20 | Phomaketide A§í¨î¤H²O¤ÚºÞ¤º¥Ö²ÓMªº²O¤ÚºÞ¥Í¦¨ Phomaketide A Inhibits Lymphangiogenesis in Human Lymphatic Endothelial Cells |
21 | ¬¡©Ê®ñª«½è½Õ±±¤B»苷¦b¨Å¸¢Àù²ÓM¤¤ªº¤Æ¾Ç¹w¨¾§@¥Î Reactive oxygen species mediate the chemopreventive effects of syringin in breast cancer cells. |
22 | ÄÄ©ú¤¤ÃĪº¤À¤l¾÷¨î¡G¥H¹ï§Ü«æ©Ê®ð¹D¯f¬r·P¬Vªº°t¤è¬°¨Ò Unraveling the Molecular Mechanism of Traditional Chinese Medicine: Formulas Against Acute Airway Viral Infections as Examples. |
23 | ÀRºÏ³õ»¤¾É¯«¸g·F/«eÅX²ÓMªº¦´Á¤À¤Æ¨Ã«P¶i¦¨¼ô Static Magnetic Field Induced Neural Stem/Progenitor Cell Early Differentiation and Promotes Maturation |
24 | ¶ÀáIËïl¥ÍKMUP-1¤ÏÂà°ª¿}¬r©Ê¬¡¤Æ¤§Kv³q¹D¸g¥ÑcAMP/PKA°T®§¸ô®|©ó¤j¹«¯Ø®q¤A«¬²ÓM Xanthine-derived KMUP-1 reverses glucotoxicity-activated Kv channels through the cAMP/PKA signaling pathway in rat pancreatic £] cells |
25 | 2,3,5,4'-¥|ßm°ò¤Gf¤A²m-2-O-£]-D-¸²µå¿}苷¹ï®ñ¤Æ°¸´á¥ÒÖJ»¤¾Éªºµ²ª½¸zÀù¤j¹«²§±`Áô²y¨_§Î¦¨ªº¤Æ¾Ç¹w¨¾§@¥Î Chemopreventive Potential of 2,3,5,4'-Tetrahydroxystilbene-2-O-£]-D-glucoside on the Formation of Aberrant Crypt Foci in Azoxymethane-Induced Colorectal Cancer in Rats. |
26 | KMUP-1«OÅ@streptozotocin¤Þ°_¸z¨t½¤°Ê¯ß¥\¯à»ÙêÂǥѬ¡¤ÆATP±Ó·P©Ê¤§¹[Â÷¤l³q¹D KMUP-1 protects against streptozotocin-induced mesenteric artery dysfunction via activation of ATP-sensitive potassium channels |
27 | ¤»²BÁ¤¶À¯À¹ï¤j¹«¨¤½¤·s¥Í¦åºÞªº§Ü¦åºÞ¥Í¦¨§@¥Î Anti-angiogenic effect of hexahydrocurcumin in rat corneal neovascularization |
28 | Sandensolide»¤¾É¤fµÄÀù²ÓM©M´³°¨³½²§ºØ²¾´Ó¼Ò«¬¤¤ªº®ñ¤ÆÀ£¤O½Õ±±ªº²ÓMä¤` Sandensolide Induces Oxidative Stress-Mediated Apoptosis in Oral Cancer Cells and in Zebrafish Xenograft Model |
Project
NO |
YEAR ¡X Source ¡X No ¡X Type
Project Name
|
Duration |
---|---|---|
1 |
114 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSTC112-2320-B-037-021-MY3 ¡X 1 Ó¤H«¬
®üºø¤ÑµMª«Rhopaloic acid A¤Î¨ä¦PÃþª«§í¨î²O¤ÚºÞ·s¥Í¥HÀ³¥Î©ó§í¨îÀùÂಾ¡G»EµJ©ó²É½uÅé¥\¯à¡BÅK¨Ì¿à©Ê¦º¤`»P»É¨Ì¿à©Ê¦º¤`(3/3)( )
|
2025/08/01 ~ 2026/07/31 |
2 |
113 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSTC112-2320-B-037-021-MY3 ¡X 1 Ó¤H«¬
®üºø¤ÑµMª«Rhopaloic acid A¤Î¨ä¦PÃþª«§í¨î²O¤ÚºÞ·s¥Í¥HÀ³¥Î©ó§í¨îÀùÂಾ¡G»EµJ©ó²É½uÅé¥\¯à¡BÅK¨Ì¿à©Ê¦º¤`»P»É¨Ì¿à©Ê¦º¤`(2/3)( )
|
2024/08/01 ~ 2026/07/31 |
3 |
112 ¡X KP °ªÂå«Ì¬ì¤j ¡X NPUST-KMU-112-P004 ¡X 1 Ó¤H«¬
±´¯Á®üºø¬¡©Ê¤Æ¦Xª«Rhopaloic Acid A³z¹LMAPK°T®§¶Ç»¼»P²É½uÅé¥\¯à¥H§í¨î²O¤Ú·s¥Í¤§§@¥Î»P¾÷Âà( )
|
2023/01/01 ~ 2023/12/31 |
4 |
112 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSTC112-2320-B-037-021-MY3 ¡X 1 Ó¤H«¬
®üºø¤ÑµMª«Rhopaloic acid A¤Î¨ä¦PÃþª«§í¨î²O¤ÚºÞ·s¥Í¥HÀ³¥Î©ó§í¨îÀùÂಾ¡G»EµJ©ó²É½uÅé¥\¯à¡BÅK¨Ì¿à©Ê¦º¤`»P»É¨Ì¿à©Ê¦º¤`(1/3)( )
|
2023/08/01 ~ 2026/07/31 |
5 |
112 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X NSTC113-2813-C-037-047-B ¡X 8 ¤j±M¾Ç¥Í¬ã¨spµe
113¦~«×¤j±M¾Ç¥Í¬ã¨spµe-ðªY·ì(ÃľÇ3)( )
|
2024/07/01 ~ 2025/02/28 |
6 |
111 ¡X DK «e¤«ÂI(ì®Õ°|) ¡X KMU-DK(A)112005 ¡X 1 Ó¤H«¬
±´°Q·O®¦JÀZ¤l¤§§Ü¯«¸gµoª¢¦¨¤À¤Î¨ä¹ï¯«¸g°h¤Æ©Ê¯e¯fªºÀø®Äµû¦ô:»EµJ©óÅK¨Ì¿à©Ê¦º¤`©M²É½uÅé¥\¯à( )
|
2023/01/01 ~ 2023/12/31 |
7 |
111 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST111-2628-B-037-009 ¡X 1 Ó¤H«¬
±´°Q¥xÆW®üºø¤G¿¥b©«Ãþ¤Æ¦Xª«ªº§Ü²O¤ÚºÞ·s¥Í¾÷¨î¤Î¨ä¹ïµoª¢PÀù»PÀùÂಾ¤§Àø®Äµû¦ô(3/3)( )
|
2022/08/01 ~ 2023/07/31 |
8 |
111 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X NSTC112-2813-C-037-058-B ¡X 8 ¤j±M¾Ç¥Í¬ã¨spµe
112¦~«×¤j±M¾Ç¥Í¬ã¨spµe-³¯Ðw¿²(¥Íª«3)( )
|
2023/07/01 ~ 2024/02/29 |
9 |
110 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST110-2628-B-037-013 ¡X 1 Ó¤H«¬
±´°Q¥xÆW®üºø¤G¿¥b©«Ãþ¤Æ¦Xª«ªº§Ü²O¤ÚºÞ·s¥Í¾÷¨î¤Î¨ä¹ïµoª¢PÀù»PÀùÂಾ¤§Àø®Äµû¦ô(2/3)( )
|
2021/08/01 ~ 2022/07/31 |
10 |
110 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X MOST111-2813-C-037-064-B ¡X 8 ¤j±M¾Ç¥Í¬ã¨spµe
111¦~«×¤j±M¾Ç¥Í¬ã¨spµe-³¯Ðw¿²(¥Íª«2)( )
|
2022/07/01 ~ 2023/02/28 |
11 |
109 ¡X KP °ªÂå«Ì¬ì¤j ¡X NPUST-KMU-109-P006 ¡X 1 Ó¤H«¬
¿A蘭¶Àଧí¨î神¸gµoª¢¾÷¨î¤Î¨ä¹ï½w¸Ñ神¸g©Ê¯kµh¤§療®Äµû¦ô( )
|
2020/01/01 ~ 2020/12/31 |
12 |
109 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST109-2628-B-037-009 ¡X 1 Ó¤H«¬
±´°Q¥xÆW®üºø¤G¿¥b©«Ãþ¤Æ¦Xª«ªº§Ü²O¤ÚºÞ·s¥Í¾÷¨î¤Î¨ä¹ïµoª¢PÀù»PÀùÂಾ¤§Àø®Äµû¦ô(1/3)( )
|
2020/08/01 ~ 2021/07/31 |
13 |
109 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X MOST110-2813-C-037-145-B ¡X 8 ¤j±M¾Ç¥Í¬ã¨spµe
110¦~«×¤j±M¾Ç¥Í¬ã¨spµe-±iÏy·_(ÃľÇ2)( )
|
2021/07/01 ~ 2022/02/28 |
14 |
108 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST108-2320-B-037-018 ¡X 1 Ó¤H«¬
¤»²BÁ¤¶À¯À¤Î¨ä¦PÃþª«§í¨î¤fµÄÀù¤Þ°_²O¤ÚºÞ·s¥Í¤ÎÂಾ¤§§@¥Î¬ã¨s( )
|
2019/08/01 ~ 2020/07/31 |
15 |
108 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X MOST109-2813-C-037-007-B ¡X 8 ¤j±M¾Ç¥Í¬ã¨spµe
109¦~«×¤j±M¾Ç¥Í¬ã¨spµe-³¯¸a¶²(Âå¾Ç3)( )
|
2020/07/01 ~ 2021/02/28 |
16 |
107 ¡X Q ·s¸u±Ð®vpµe(®Õ¤º) ¡X KMU-Q108014 ¡X
±´°Q¬õ²yÁ¤µÑ¨úª«§í¨î¦ÞÀù²ÓM¤§«IŧÂಾ¤§¾÷¨î¬ÛÃö¬ã¨s( )
|
2019/01/01 ~ 2019/12/31 |
17 |
107 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X MOST108-2813-C-037-056-B ¡X 8 ¤j±M¾Ç¥Í¬ã¨spµe
108¦~«×¤j±M¾Ç¥Í¬ã¨spµe-²øµ®´D(Âå§Þ3)( )
|
2019/07/01 ~ 2020/02/29 |
18 |
106 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST106-2320-B-037-031 ¡X 1 Ó¤H«¬
µû¦ô·s¿oROCK§í¨î¾¯§í¨î¨ÅÀù²ÓM¤§«IŧÂಾ¡B¤W¥Ö-¶¡½èÂà´«©Mµ²¦X¤Æ( )
|
2017/10/01 ~ 2018/09/30 |
19 |
106 ¡X Q ·s¸u±Ð®vpµe(®Õ¤º) ¡X KMU-Q107009 ¡X
µû¦ô·s¿oROCK§í¨î¾¯§í¨î¦ÞÀù²ÓM¤§«Iŧ¡BÂಾ©M¤W¥Ö¶¡½èÂà¤Æ¤§¾÷¨î¬ÛÃö¬ã¨s( )
|
2018/01/01 ~ 2018/12/31 |